RU486 (mifepristone) ameliorates cognitive dysfunction and reverses the down-regulation of astrocytic N-myc downstream-regulated gene 2 in streptozotocin-induced type-1 diabetic rats

Neuroscience

Volumn 190, Issue , 2011, Pages 156-165

  Zuo, Z F ^a,b   Wang, W ^a   Niu, L ^a   Kou, Z Z ^a   Zhu, C ^a   Zhao, X H ^a   Luo, D S ^a   Zhang, T ^a   Zhang, F X ^a   Liu, X Z ^b   Wu, S X ^a   Li, Y Q ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b JINZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Diabetic cognitive dysfunction; GFAP; Glucocorticoids receptor; N myc downstream regulated gene 2; RU486

Indexed keywords

CORTICOSTERONE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUCOCORTICOID RECEPTOR; MIFEPRISTONE; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL DIFFERENTIATION; CELL MATURATION; COGNITIVE DEFECT; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DOWN REGULATION; DRUG DOSE COMPARISON; GENE; IMMUNOHISTOCHEMISTRY; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MAZE TEST; NDRG2 GENE; NONHUMAN; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR BLOCKING; STREPTOZOCIN DIABETES; WESTERN BLOTTING;

ANIMALS; ASTROCYTES; COGNITION; COGNITION DISORDERS; CORTICOSTERONE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DOWN-REGULATION; MALE; MAZE LEARNING; MIFEPRISTONE; NERVE TISSUE PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; STREPTOZOCIN;

EID: 80051594444     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.06.025     Document Type: Article

References (51)

1. Baydas G., Nedzvetskii V.S., Nerush P.A., Kirichenko S.V., Yoldas T. Altered expression of NCAM in hippocampus and cortex may underlie memory and learning deficits in rats with streptozotocin-induced diabetes mellitus. Life Sci 2003, 73:1907-1916.
2. Baydas G., Reiter R.J., Yasar A., Tuzcu M., Akdemir I., Nedzvetskii V.S. Melatonin reduces glial reactivity in the hippocampus, cortex, and cerebellum of streptozotocin-induced diabetic rats. Free Radic Biol Med 2003, 35:797-804.
3. Belanoff J.K., Gross K., Yager A., Schatzberg A.F. Corticosteroids and cognition. J Psychiatr Res 2001, 35:127-145.
4. Ben Achour S., Pascual O. Glia: the many ways to modulate synaptic plasticity. Neurochem Int 2010, 57:440-445.
5. Bitar M.S. Glucocorticoid dynamics and impaired wound healing in diabetes mellitus. Am J Pathol 1998, 152:547-554.
6. Boulkroun S., Fay M., Zennaro M.C., Escoubet B., Jaisser F., Blot-Chabaud M., Farman N., Courtois-Coutry N. Characterization of rat NDRG2 (N-Myc downstream regulated gene 2), a novel early mineralocorticoid-specific induced gene. J Biol Chem 2002, 277:31506-31515.
7. Bruehl H., Rueger M., Dziobek I., Sweat V., Tirsi A., Javier E., Arentoft A., Wolf O.T., Convit A. Hypothalamic-pituitary-adrenal axis dysregulation and memory impairments in type 2 diabetes. J Clin Endocrinol Metab 2007, 92:2439-2445.
8. Caudle R.M. Memory in astrocytes: a hypothesis. Theor Biol Med Model 2006, 3:2.
9. Chan O., Inouye K., Vranic M., Matthews S.G. Hyperactivation of the hypothalamo-pituitary-adrenocortical axis in streptozotocin-diabetes is associated with reduced stress responsiveness and decreased pituitary and adrenal sensitivity. Endocrinology 2002, 143:1761-1768.
10. Choi S.C., Kim K.D., Kim J.T., Kim J.W., Yoon D.Y., Choe Y.K., Chang Y.S., Paik S.G., Lim J.S. Expression and regulation of NDRG2 (N-myc downstream regulated gene 2) during the differentiation of dendritic cells. FEBS Lett 2003, 553:413-418.
11. Chou Y.C., Luttge W.G., Sumners C. Expression of mineralocorticoid type I and glucocorticoid type II receptors in astrocyte glia as a function of time in culture. Brain Res Dev Brain Res 1991, 61:55-61.
12. Coleman E., Judd R., Hoe L., Dennis J., Posner P. Effects of diabetes mellitus on astrocyte GFAP and glutamate transporters in the CNS. Glia 2004, 48:166-178.
13. Coleman E.S., Dennis J.C., Braden T.D., Judd R.L., Posner P. Insulin treatment prevents diabetes-induced alterations in astrocyte glutamate uptake and GFAP content in rats at 4 and 8 weeks of diabetes duration. Brain Res 2010, 1306:131-141.
14. Crossin K.L., Tai M.H., Krushel L.A., Mauro V.P., Edelman G.M. Glucocorticoid receptor pathways are involved in the inhibition of astrocyte proliferation. Proc Natl Acad Sci U S A 1997, 94:2687-2692.
15. De Kloet E.R., Vreugdenhil E., Oitzl M.S., Joëls M. Brain corticosteroid receptor balance in health and disease. Endocr Rev 1998, 19:269-301.
16. DeBattista C., Belanoff J. The use of mifepristone in the treatment of neuropsychiatric disorders. Trends Endocrinol Metab 2006, 17:117-121.
17. Douma B.R., Korte S.M., Buwalda B., la Fleur S.E., Bohus B., Luiten P.G. Repeated blockade of mineralocorticoid receptors, but not of glucocorticoid receptors impairs food rewarded spatial learning. Psychoneuroendocrinology 1998, 23:33-44.
18. Friedman J.E., Sun Y., Ishizuka T., Farrell C.J., McCormack S.E., Herron L.M., Hakimi P., Lechner P., Yun J.S. Phosphoenolpyruvate carboxykinase (GTP) gene transcription and hyperglycemia are regulated by glucocorticoids in genetically obese db/db transgenic mice. J Biol Chem 1997, 272:31475-31481.
19. Gao C.J., Li J.P., Wang W., Lü B.C., Niu L., Zhu C., Wei Y.Y., Zhang T., Wu S.X., Chai W., Li Y.Q. Effects of intracerebroventricular application of the delta opioid receptor agonist [D-Ala2, D-Leu5] enkephalin on neurological recovery following asphyxial cardiac arrest in rats. Neuroscience 2010, 168:531-542.
20. Grzeda E., Wiśniewska R.J. Differentiations of the effect of NMDA on the spatial learning of rats with 4 and 12 week diabetes mellitus. Acta Neurobiol Exp (Wars) 2008, 68:398-406.
21. Jacobson A.M., Ryan C.M., Cleary P.A., Waberski B.H., Weinger K., Musen G., Dahms W. Biomedical risk factors for decreased cognitive functioning in type 1 diabetes: an 18 year follow-up of the Diabetes Control and Complications Trial (DCCT) cohort. Diabetologia 2011, 54:245-255.
22. Joëls M., de Kloet E.R. Mineralocorticoid and glucocorticoid receptors in the brain. Implications for ion permeability and transmitter systems. Prog Neurobiol 1994, 43:1-36.
23. Lebed Y.V., Orlovsky M.A., Nikonenko A.G., Ushakova G.A., Skibo G.G. Early reaction of astroglial cells in rat hippocampus to streptozotocin-induced diabetes. Neurosci Lett 2008, 444:181-185.
24. Li Z.G., Zhang W., Grunberger G., Sima A.A. Hippocampal neuronal apoptosis in type 1 diabetes. Brain Res 2002, 946:221-231.
25. Liu J., Zhang J., Wang X., Li Y., Chen Y., Li K., Zhang J., Yao L., Guo G. HIF-1 and NDRG2 contribute to hypoxia-induced radioresistance of cervical cancer Hela cells. Exp Cell Res 2010, 316:1985-1993.
26. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
27. Lusis E.A., Watson M.A., Chicoine M.R., Lyman M., Roerig P., Reifenberger G., Gutmann D.H., Perry A. Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma. Cancer Res 2005, 65:7121-7126.
28. Magistretti P.J. Neuron-glia metabolic coupling and plasticity. J Exp Biol 2006, 209:2304-2311.
29. Mahesh V.B., Dhandapani K.M., Brann D.W. Role of astrocytes in reproduction and neuroprotection. Mol Cell Endocrinol 2006, 246:1-9.
30. McEwen B.S., Sapolsky R.M. Stress and cognitive function. Curr Opin Neurobiol 1995, 5:205-216.
31. Mitchelmore C., Büchmann-Møller S., Rask L., West M.J., Troncoso J.C., Jensen N.A. NDRG2: a novel Alzheimer's disease associated protein. Neurobiol Dis 2004, 16:48-58.
32. Monk J.M., Makinen K., Shrum B., Woodward B. Blood corticosterone concentration reaches critical illness levels early during acute malnutrition in the weanling mouse. Exp Biol Med (Maywood) 2006, 231:264-268.
33. Nichols N.R. Ndrg2, a novel gene regulated by adrenal steroids and antidepressants, is highly expressed in astrocytes. Ann N Y Acad Sci 2003, 1007:349-356.
34. Nichols N.R., Finch C.E. Gene products of corticosteroid action in hippocampus. Ann N Y Acad Sci 1994, 746:145-154. [discussion: 154-146].
35. Nichols N.R., Osterburg H.H., Masters J.N., Millar S.L., Finch C.E. Messenger RNA for glial fibrillary acidic protein is decreased in rat brain following acute and chronic corticosterone treatment. Brain Res Mol Brain Res 1990, 7:1-7.
36. Okuda T., Kokame K., Miyata T. Differential expression patterns of NDRG family proteins in the central nervous system. J Histochem Cytochem 2008, 56:175-182.
37. Pace T.W., Spencer R.L. Disruption of mineralocorticoid receptor function increases corticosterone responding to a mild, but not moderate, psychological stressor. Am J Physiol Endocrinol Metab 2005, 288:E1082-E1088.
38. Paxinos G., Watson C. The rat brain in stereotaxic coordinates (compact third edition) 1996, Academic Press, New York.
39. Ratka A., Sutanto W., Bloemers M., de Kloet E.R. On the role of brain mineralocorticoid (type I) and glucocorticoid (type II) receptors in neuroendocrine regulation. Neuroendocrinology 1989, 50:117-123.
40. Revsin Y., Rekers N.V., Louwe M.C., Saravia F.E., De Nicola A.F., de Kloet E.R., Oitzl M.S. Glucocorticoid receptor blockade normalizes hippocampal alterations and cognitive impairment in streptozotocin-induced type 1 diabetes mice. Neuropsychopharmacology 2009, 34:747-758.
41. Revsin Y., Saravia F., Roig P., Lima A., de Kloet E.R., Homo-Delarche F., De Nicola A.F. Neuronal and astroglial alterations in the hippocampus of a mouse model for type 1 diabetes. Brain Res 2005, 1038:22-31.
42. Saravia F.E., Beauquis J., Revsin Y., Homo-Delarche F., de Kloet E.R., De Nicola A.F. Hippocampal neuropathology of diabetes mellitus is relieved by estrogen treatment. Cell Mol Neurobiol 2006, 26:943-957.
43. Saravia F.E., Revsin Y., Gonzalez Deniselle M.C., Gonzalez S.L., Roig P., Lima A., Homo-Delarche F., De Nicola A.F. Increased astrocyte reactivity in the hippocampus of murine models of type 1 diabetes: the nonobese diabetic (NOD) and streptozotocin-treated mice. Brain Res 2002, 957:345-353.
44. Šimonová Z., Sterbová K., Brozek G., Komárek V., Syková E. Postnatal hypobaric hypoxia in rats impairs water maze learning and the morphology of neurones and macroglia in cortex and hippocampus. Behav Brain Res 2003, 141:195-205.
45. Slezak M., Pfrieger F.W. New roles for astrocytes: regulation of CNS synaptogenesis. Trends Neurosci 2003, 26:531-535.
46. Stranahan A.M., Arumugam T.V., Cutler R.G., Lee K., Egan J.M., Mattson M.P. Diabetes impairs hippocampal function through glucocorticoid-mediated effects on new and mature neurons. Nat Neurosci 2008, 11:309-317.
47. Takahashi K., Yamada M., Ohata H., Honda K., Yamada M. Ndrg2 promotes neurite outgrowth of NGF-differentiated PC12 cells. Neurosci Lett 2005, 388:157-162.
48. Vielkind U., Walencewicz A., Levine J.M., Bohn M.C. Type II glucocorticoid receptors are expressed in oligodendrocytes and astrocytes. J Neurosci Res 1990, 27:360-373.
49. Wolf O.T. HPA axis and memory. Best Pract Res Clin Endocrinol Metab 2003, 17:287-299.
50. Wrighten S.A., Piroli G.G., Grillo C.A., Reagan L.P. A look inside the diabetic brain: contributors to diabetes-induced brain aging. Biochim Biophys Acta 2009, 1792:444-453.
51. Yang L., Li F., Zhang H., Ge W., Mi C., Sun R., Liu C. Astrocyte activation and memory impairment in the repetitive febrile seizures model. Epilepsy Res 2009, 86:209-220.